Evidence map›Paper›PMID 38131682›Full record

ArticleClinics and practice2023

Combined Results of Two Cross-Sectional Surveys on the Participation in Clinical Trials and the e-Consent Procedure in the Landscape of Haematology.

Bert Heyrman, Stef Meers, Ann Van De Velde, Sébastien Anguille

Abstract read
In one paragraph

Article in Clinics and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bert HeyrmanZiekenhuis Netwerk Antwerpen, Department of Haematology, 2020 Antwerp, Belgium.ORCID 0000-0001-5816-5375
Stef MeersAlgemeen Ziekenhuis KLINA, Department of Haematology, 2930 Brasschaat, Belgium.
Ann Van De VeldeDepartment of Haematology, University Hospital Antwerp, 2650 Edegem, Belgium.
Sébastien AnguilleDepartment of Haematology, University Hospital Antwerp, 2650 Edegem, Belgium.ORCID 0000-0002-1951-6715

Funding

Novartis (Belgium) ON410REV
6 · The paper itself

Abstract

Despite the motivation of oncology patients to take part in clinical trials, only a minority of them are enrolled in clinical trials. Implementation of new practical procedures can become a barrier that withholds patients from participating in clinical trials. Treating physicians are crucial in augmenting trial accrual. The drivers that promote physicians to allocate patients for clinical trials need further assessment. We conducted two separate cross-sectional surveys, addressing patients with a haematological disease in one survey and haematologists in another survey. The patient survey was filled out by 420 patients. Significant relationships between the willingness to participate in a trial and trial knowledge (

Indexed as

clinical trial barriersclinical trial enrolmentclinical trialse-consentpatient-reported outcomephysician-reported outcome

Identifiers

PMID38131682
PMCPMC10742482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.